1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with Lung Neoplasms in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (50.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boot, H; Gortzak, E; Taal, BG; Van den Hout, BM; Zoetmulder, FA | 1 |
Ellman, M; Gunnarsson, PO; Hansen, HH; Hansson, K; Hartley-Asp, B; Polacek, J; Vibe-Petersen, J | 1 |
Bach, F; Dombernowsky, P; Hansen, HH; Sørensen, JB; Vibe-Petersen, J | 2 |
Drings, P; Edler, L; Fiebig, HH; Gatzemeier, U; Hinke, A; Rieche, K; Tessen, HW | 1 |
Bach, F; Hansen, HH; Pedersen, AG; Smyth, J; Vibe-Petersen, J | 1 |
Pratesi, G; Savi, G | 1 |
Dean, SW; Gibson, NW; Tew, KD | 1 |
Christensen, IJ; Hansen, HH; Roed, H; Spang-Thomsen, M; Vindeløv, LL | 1 |
Hansen, M; Heaf, JG | 1 |
1 trial(s) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Lung Neoplasms
Article | Year |
---|---|
Chemotherapy with tauromustine in advanced non-small cell lung cancer. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Follow-Up Studies; Germany, West; Humans; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Metastasis; Nitrosourea Compounds; Survival Rate; Taurine | 1990 |
9 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Lung Neoplasms
Article | Year |
---|---|
Long-term survival in two cases of colorectal carcinoma following a new chemotherapy regimen and subsequent metastasectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Taurine | 1995 |
Chromosome aberrations and pharmacokinetics in patients receiving tauromustine as either a single or a repeated dose.
Topics: Antineoplastic Agents; Chromosome Aberrations; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Lung Neoplasms; Nitrosourea Compounds; Taurine | 1996 |
Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Remission Induction; Taurine; Vindesine | 1990 |
TCNU in adenocarcinoma of the lung: a phase II study with divided doses.
Topics: Adenocarcinoma; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Nitrosourea Compounds; Taurine | 1990 |
A phase II trial of TCNU in patients with squamous, adeno and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Taurine | 1989 |
Effects of tauromustine, a water-soluble nitrosourea compound on NMU-1 murine lung tumor.
Topics: Animals; Carmustine; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Nitrosourea Compounds; Taurine | 1989 |
The effect of a novel taurine nitrosourea, 1-(2-chloroethyl)-3-[2-(dimethylaminosulfonyl)ethyl]-1-nitrosour ea (TCNU) on cytotoxicity, DNA crosslinking and glutathione reductase in lung carcinoma cell lines.
Topics: Animals; Cell Line; Cell Survival; DNA, Neoplasm; Glutathione Reductase; Humans; Lomustine; Lung Neoplasms; Mammary Neoplasms, Experimental; Nitrosourea Compounds; Rats; Streptozocin; Taurine | 1987 |
In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines.
Topics: Carcinoma, Small Cell; Carmustine; Cell Cycle; Cell Line; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Flow Cytometry; Humans; Lung Neoplasms; Nitrosourea Compounds; Taurine; Tumor Stem Cell Assay | 1987 |
Treatment of refractory cancer-associated hypercalcemia with aminohydroxypropylidene diphosphonate.
Topics: Adenocarcinoma; Antineoplastic Agents; Diphosphonates; Female; Humans; Hypercalcemia; Lung Neoplasms; Middle Aged; Nitrosourea Compounds; Pamidronate; Taurine | 1988 |